InvestorsHub Logo
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: None

Friday, 01/26/2018 9:14:05 AM

Friday, January 26, 2018 9:14:05 AM

Post# of 3020
ABBV reports 4Q17 HCV—(i.e. Mavyret)—sales of $510M, blowing past consensus estimates:

https://finance.yahoo.com/news/abbvie-reports-full-fourth-quarter-125100560.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News